Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies-Reference-Cited by-同舟云学术

Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies

Published:2021-12 Issue: Volume: Page:
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Geng Bob,Bachert Claus,Busse William W.,Gevaert Philippe,Lee Stella E.,Niederman Michael S.,Chen Zhen,Lu Xin,Khokhar Faisal A.,Kapoor Upender,Pandit-Abid Nami,Jacob-Nara Juby A.,Rowe Paul J.,Deniz Yamo,Ortiz Benjamin

Funder

Sanofi US

Regeneron Pharmaceuticals Inc

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference34 articles.

1. Epidemiology of asthma in children and adults;Dharmage;Front Pediatr,2019

2. Impact of respiratory virus infections in exacerbation of acute and chronic rhinosinusitis;Tan;Curr Allergy Asthma Rep,2017

3. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-γ and IL-4;Soyka;J Allergy Clin Immunol,2012

4. Epithelium dysfunction in asthma;Holgate;J Allergy Clin Immunol,2007

5. Role of viral respiratory infections in asthma and asthma exacerbations;Busse;Lancet,2010

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of dupilumab on the disease burden in children and adolescents with atopic dermatitis: A population‐based cohort study;Allergy;2024-08-21

2. Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma;Allergy;2024-08

3. Development of allergic bronchopulmonary aspergillosis in a patient with nontuberculous mycobacterial‐pulmonary disease successfully treated with dupilumab: A case report and literature review;Respirology Case Reports;2024-07

4. Dupilumab-induced rhinitis in severe asthma patients: A case series;Respiratory Medicine and Research;2024-06

5. The Possible Roles of IL-4/IL-13 in the Development of Eosinophil-Predominant Severe Asthma;Biomolecules;2024-05-02